Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Oncology Reports|April 18, 2000
A multivariate analysis for predicting cisplatin-induced delayed emesisX Pivot, N Marghali, M C Etienne, et al.
La Revue De Medecine Interne|September 28, 2015
[Symptomatic extramedullary haematopoiesis in β-thalassemia: A retrospective single centre study]F Maazoun, J Gellen Dautremer, A Boutekadjirt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceI H Kunkler, R Audisio, Y Belkacemi, et al.
Pharmacotherapy|December 17, 1997
Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factorsJ L Lagrange, B Médecin, M C Etienne, et al.
Bulletin Du Cancer|February 1, 1997
[Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]J L Molitor, A Llombart, J M Guinebretière, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)C Delbaldo, D Serin, M Mousseau, et al.
Journal of Clinical Pathology|March 1, 1997
Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancerM Lagrange, J M Ferrero, J L Lagrange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 30, 2016
[Repeated radiation dose effect and DNA repair: Importance of the individual factor and the time interval between the doses]M Viau, A-F Perez, L Bodgi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2000
[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer]A Hasbini, C Le Péchoux, B Roche, et al.
Oncogene|December 5, 2000
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancersJ C Ahomadegbe, S Tourpin, M Kaghad, et al.
Pageof 15